Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue 9
Submit an article Journal homepage
1,751
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Bispecific antibodies, nanoparticles and cells: bringing the right cells to get the job done

Junnan TangNorth Carolina State University, College of Veterinary Medicine, Department of Molecular Biomedical Sciences and Center for Comparative Medicine and Translational Research, Raleigh, NC, USA;The First Affiliated Hospital of Zhengzhou University, Department of Cardiology, Zhengzhou, China
, PhD,
Deliang ShenThe First Affiliated Hospital of Zhengzhou University, Department of Cardiology, Zhengzhou, China
, PhD MD,
Jinying ZhangThe First Affiliated Hospital of Zhengzhou University, Department of Cardiology, Zhengzhou, China
, PhD MD,
Frances S LiglerUniversity of North Carolina at Chapel Hill and North Carolina State University, Department of Biomedical Engineering, 1060 William Moore Drive, Raleigh, NC 27607, USA+1 919 513 6157; +1 919 513 7301; [email protected]; [email protected]
, DPhil DSc &
Ke ChengNorth Carolina State University, College of Veterinary Medicine, Department of Molecular Biomedical Sciences and Center for Comparative Medicine and Translational Research, Raleigh, NC, USA;University of North Carolina at Chapel Hill and North Carolina State University, Department of Biomedical Engineering, 1060 William Moore Drive, Raleigh, NC 27607, USA+1 919 513 6157; +1 919 513 7301; [email protected]; [email protected];Soochow University, The Cyrus Tang Hematology Center, Suzhou, China
, PhD (Associate Professor of Regenerative Medicine)
Pages 1251-1255 | Published online: 25 May 2015

Bibliography

  • Thakur A, Lum LG. Cancer therapy with bispecific antibodies: Clinical experience. Curr Opin Mol Ther 2010;12:340-9
  • Lum LG, Davol PA, Lee RJ. The new face of bispecific antibodies: targeting cancer and much more. Exp Hematol 2006;34:1-6
  • Cheng K, Shen D, Hensley MT, et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat Commun 2014; published online 10 September 2014; 10.1038/ncomms5880
  • Choi BD, Cai M, Bigner DD, et al. Bispecific antibodies engage T cells for antitumor immunotherapy. Expert Opin Biol Ther 2011;11:843-53
  • De Gast GC, Van Houten AA, Haagen IA, et al. Clinical experience with CD3 x CD19 bispecific antibodies in patients with B cell malignancies. J Hematother 1995;4:433-7
  • Baeuerle PA, Reinhardt C. Bispecific T-cell engaging antibodies for cancer therapy. Cancer Res 2009;69:4941-4
  • Davol PA, Smith JA, Kouttab N, et al. Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice. Clin Prostate Cancer 2004;3:112-21
  • Reusch U, Sundaram M, Davol PA, et al. Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model. Clin Cancer Res 2006;12:183-90
  • Lee RJ, Fang Q, Davol PA, et al. Antibody targeting of stem cells to infarcted myocardium. Stem Cells 2007;25:712-17
  • Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:14-18
  • Nagamine H, Watanabe G, Shiobara S, et al. Intramyocardial CD34+ cell transplantation combined with off-pump coronary artery bypass grafting. Heart Surg Forum 2004;7:285-7
  • Zhao TC, Tseng A, Yano N, et al. Targeting human CD34+ hematopoietic stem cells with anti-CD45 × anti-myosin light-chain bispecific antibody preserves cardiac function in myocardial infarction. J Appl Physiol (1985). 2008;104:1793-800
  • Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021
  • Cheng K, Li TS, Malliaras K, et al. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010;106:1570-81
  • Cheng K, Malliaras K, Li TS, et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012;21:1121-35

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.